Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation Marcia L. Buck Leading Article 30 September 2012 Pages: 403 - 417
Pharmacokinetics of Pegylated Liposomal Doxorubicin Alberto GabizonHilary ShmeedaYechezkel Barenholz Review Article 30 September 2012 Pages: 419 - 436
Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress Edzard SchwedhelmRenke MaasRainer H. Böger Review Article 30 September 2012 Pages: 437 - 459
Transdermal Drug Delivery of Insulin with Ultradeformable Carriers Gregor Cevc Review Article 30 September 2012 Pages: 461 - 474
No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers Linda C. JohanssonMagnus AnderssonUlf G. Eriksson Original Research Article 30 September 2012 Pages: 475 - 484
No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran Troy C. SarichRenli TengUlf G. Eriksson Original Research Article 30 September 2012 Pages: 485 - 492
Aminoglycoside Dosages and Nephrotoxicity Florent RougierMichel DucherPascal Maire Original Research Article 30 September 2012 Pages: 493 - 500